0.7665
Promis Neurosciences Inc stock is traded at $0.7665, with a volume of 576.49K.
It is down -0.60% in the last 24 hours and up +56.83% over the past month.
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
See More
Previous Close:
$0.7711
Open:
$0.7444
24h Volume:
576.49K
Relative Volume:
0.09
Market Cap:
$25.06M
Revenue:
-
Net Income/Loss:
$-563.30K
P/E Ratio:
-3.8402
EPS:
-0.1996
Net Cash Flow:
$-22.23M
1W Performance:
-22.30%
1M Performance:
+56.83%
6M Performance:
-15.72%
1Y Performance:
-46.77%
Promis Neurosciences Inc Stock (PMN) Company Profile
Name
Promis Neurosciences Inc
Sector
Industry
Phone
416-847-6898
Address
SUITE 200, 1920 YONGE STREET, TORONTO
Compare PMN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
PMN
Promis Neurosciences Inc
|
0.7665 | 25.21M | 0 | -563.30K | -22.23M | -0.1996 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Promis Neurosciences Inc Stock (PMN) Latest News
Intraday pattern recognizer results for ProMIS Neurosciences Inc.Free Secure Return Focused Investment Plan - Newser
Should I buy ProMIS Neurosciences Inc. stock before earningsSwing Gain Strategy with Entry Forecast - Newser
Combining price and volume data for ProMIS Neurosciences Inc.Weekly Stock Picks with Trend Confidence - Newser
Multi factor analysis applied to ProMIS Neurosciences Inc.Summary of Reliable Long-Term Trade Models - Newser
Leading vs lagging indicators on ProMIS Neurosciences Inc. performanceBuy and Exit Strategy Based on Momentum - Newser
What makes ProMIS Neurosciences Inc. stock price move sharplyAI Powered Growth Plan From AI Tools - jammulinksnews.com
ProMIS Neurosciences Inc. stock daily chart insightsFree AI Screening for Swing Trade Picks - Newser
Is ProMIS Neurosciences Inc. forming a reversal patternFree High Yield Stock Screening Results - Newser
What earnings revisions data tells us about ProMIS Neurosciences Inc.Low Risk Strategy with Smart Entry Zones - Newser
ProMIS Neurosciences Inc. stock momentum explainedSwing Reversal Forecast Based on Patterns - Newser
What is ProMIS Neurosciences Inc. company’s growth strategyValue Investing Picks For Every Investor - jammulinksnews.com
ProMIS Neurosciences Inc. Earnings Report Breakdown: What Investors Should KnowFree Swing Trade With Risk Management - Newser
Published on: 2025-07-31 04:12:44 - Newser
Can swing trading help recover from ProMIS Neurosciences Inc. lossesFree Weekly Watchlist of High Movers - Newser
ProMIS Neurosciences Inc. Charts Flash Early Recovery SignalsCapital Preserving Trade Plan Templates Shared - metal.it
Will a bounce in ProMIS Neurosciences Inc. offer an exitPredictive Model for Intraday Swing Forecast - Newser
Earnings visualization tools for ProMIS Neurosciences Inc.Daily Pick Forecast with Entry Zones - Newser
How to build a custom watchlist for ProMIS Neurosciences Inc.Steady Return Plan Based on Data Analysis - Newser
ProMIS Neurosciences to Showcase Protein-Misfolding Drug - GlobeNewswire
ProMIS Neurosciences Inc. Uptrend in Early Stages Indicators Say YesVerified Signal From Chart Patterns Detected - metal.it
Published on: 2025-07-29 18:58:10 - metal.it
ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference - Toronto Star
Is ProMIS Neurosciences Inc. stock poised for growthAI Screener Based Stock Summary Report - Newser
Sectors Driving Future Growth for ProMIS Neurosciences Inc. StockSwing Trade Entry and Exit Point Analysis - Newser
ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the… - Informazione.it
ProMIS Neurosciences Announces Private Placement Financing - GlobeNewswire
When is ProMIS Neurosciences Inc. stock expected to show significant growthPre Market Entry Points To Watch Now - jammulinksnews.com
Will ProMIS Neurosciences Inc. Hold Gains Into CloseStock Market Watch With Alerts Shows Unusual Activity - metal.it
Is it the right time to buy ProMIS Neurosciences Inc. stockExplosive earnings growth - jammulinksnews.com
ProMIS Neurosciences Inc (PMN) Stock: A Year of Highs and Lows in the Market - investchronicle.com
ProMIS Neurosciences raises $12 million through PIPE financing and warrants - Investing.com India
ProMIS Neurosciences raises $12 million through PIPE financing and warrants By Investing.com - Investing.com South Africa
Intrinsic Value of ProMIS Neurosciences Inc. Stock: Is It Undervalued or OvervaluedPrice Forecast Based on AI Analysis - Newser
Building trade automation scripts for ProMIS Neurosciences Inc.Predictive Analytics for Equity Growth Potential - Newser
What is the risk reward ratio of investing in ProMIS Neurosciences Inc. stockAchieve rapid wealth accumulation with smart picks - jammulinksnews.com
Clinical-Stage Biotech ProMIS Raises $12M to Advance Novel Alzheimer's Treatment PMN310 - Stock Titan
What earnings revisions data tells us about ProMIS Neurosciences Inc. Free Buy Low Sell High Stock Watch - Newser
How strong is ProMIS Neurosciences Inc. company’s balance sheetMaximize gains with strategic stock entries - jammulinksnews.com
Promis Neurosciences Inc Stock (PMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):